SSO:ARCA-ProShares Ultra S&P500 (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 97.23

Change

+0.14 (+0.14)%

Market Cap

USD 1.61B

Volume

2.68M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P 500?. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a measure of large-cap U.S. stock market performance. It is a float-adjusted, market capitalization-weighted index of 500 U.S. operating companies and real estate investment trusts selected through a process. The fund is non-diversified.

Inception Date: 19/06/2006

Primary Benchmark: S&P 500 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.9%

Management Expense Ratio: 0.90 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-11 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

-1.10 (-3.36%)

USD 11.50B
QLD ProShares Ultra QQQ 0.95 %

-0.39 (-0.35%)

USD 7.95B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+11.15 (+2.17%)

USD 5.90B
UPRO ProShares UltraPro S&P500 0.92 %

-0.93 (-0.97%)

USD 4.34B
TECL Direxion Daily Technology Bull.. 1.17 %

+0.20 (+0.21%)

USD 3.15B
YINN Direxion Daily FTSE China Bull.. 1.02 %

-3.54 (-11.10%)

USD 2.02B
USD ProShares Ultra Semiconductors 0.95 %

+0.75 (+1.06%)

USD 1.40B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

-12.47 (-8.64%)

USD 0.99B
DPST Direxion Daily Regional Banks .. 1.02 %

-2.58 (-1.69%)

USD 0.88B
UDOW ProShares UltraPro Dow30 0.95 %

-2.69 (-2.49%)

USD 0.79B

ETFs Containing SSO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -62.64% 39% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.64% 39% F 3% F
Trailing 12 Months  
Capital Gain -56.61% 37% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.61% 37% F 4% F
Trailing 5 Years  
Capital Gain -64.92% 38% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.92% 38% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain 14.26% 30% F 75% C
Dividend Return 14.54% 30% F 71% C-
Total Return 0.28% 23% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 54.39% 75% C 17% F
Risk Adjusted Return 26.74% 51% F 43% F
Market Capitalization 1.61B 94% A 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.